XNAS
EXPO
Market cap3.39bUSD
Oct 08, Last price
69.78USD
1D
1.20%
1Q
12.37%
Jan 2017
131.44%
Name
Exponent Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific division offers a broad spectrum of services encompassing biomechanics, biomedical sciences, structural analysis, civil engineering, construction advisory, data analytics, electrical and computer science, human factors, materials and corrosion science, mechanical engineering, polymer chemistry, thermal dynamics, and vehicle system engineering. Concurrently, the Environmental and Health segment specializes in areas such as chemical regulatory compliance, food safety, ecological and biological studies, earth and environmental sciences, and various health-related scientific fields. With expertise spanning approximately 90 technical disciplines, Exponent is dedicated to addressing complex and pressing issues for its stakeholders. Its client base is diverse, covering industries like chemicals, construction, consumer products, energy, food and beverage, government, life sciences, insurance, manufacturing, technology, heavy industrial equipment, and transportation. The company, originally established in 1967 as The Failure Group, Inc., rebranded as Exponent, Inc. in 1998, and its headquarters are located in Menlo Park, California.
Key people
Paul Johnston
Independent Chairman of the Board · since 2019
Catherine Corrigan
President, Chief Executive Officer, Director · since 2018
Richard Schlenker
Chief Financial Officer, Executive Vice President, Corporate Secretary · since 2010
Brian Kundert
Chief Human Resources Officer · since 2024
Brad James
Group Vice President · since 2020
John Pye
Group Vice President · since 2014
Joseph Rakow
Group Vice President · since 2023
Richard Reiss
Group Vice President · since 2015
Maureen Reitman
Group Vice President · since 2020
Joseph Sala
Group Vice President · since 2024
George Brown
Independent Director · since 2020
Independent Director · since 2017
Independent Director · since 2023
Independent Director · since 2014
Legal address
c/o The Corporation Trust Company, Corporation Trust Center, 1209 Orange Street
Wilmington, DE 19801
US
Wilmington, DE 19801
US
Headquarters
149 Commonwealth Drive
Menlo Park, CA 94025
US
Menlo Park, CA 94025
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑00 | 2025‑00 | 2023‑12 | 2023‑12 | 2022‑12 | 2022‑12 | 2021‑12 | 2021‑00 | 2020‑12 | 2020‑00 | 2019‑12 | 2018‑12 | 2018‑12 | 2017‑12 | 2017‑12 | 2016‑12 | 2016‑12 | |
| Income | |||||||||||||||||
Revenues | |||||||||||||||||
Cost of revenue | |||||||||||||||||
Unusual Expense (Income) | |||||||||||||||||
NOPBT | |||||||||||||||||
NOPBT Margin | |||||||||||||||||
Operating Taxes | |||||||||||||||||
Tax Rate | |||||||||||||||||
NOPAT | |||||||||||||||||
Net income | |||||||||||||||||
Dividends | |||||||||||||||||
Dividend yield | |||||||||||||||||
Proceeds from repurchase of equity | |||||||||||||||||
BB yield | |||||||||||||||||
| Debt | |||||||||||||||||
Debt current | |||||||||||||||||
Long-term debt | |||||||||||||||||
Deferred revenue | |||||||||||||||||
Other long-term liabilities | |||||||||||||||||
Net debt | |||||||||||||||||
| Cash flow | |||||||||||||||||
Cash from operating activities | |||||||||||||||||
CAPEX | |||||||||||||||||
Cash from investing activities | |||||||||||||||||
Cash from financing activities | |||||||||||||||||
FCF | |||||||||||||||||
| Balance | |||||||||||||||||
Cash | |||||||||||||||||
Long term investments | |||||||||||||||||
Excess cash | |||||||||||||||||
Stockholders' equity | |||||||||||||||||
Invested Capital | |||||||||||||||||
ROIC | |||||||||||||||||
ROCE | |||||||||||||||||
| EV | |||||||||||||||||
Common stock shares outstanding | |||||||||||||||||
Price | |||||||||||||||||
Market cap | |||||||||||||||||
EV | |||||||||||||||||
EBITDA | |||||||||||||||||
EV/EBITDA | |||||||||||||||||
Interest | |||||||||||||||||
Interest/NOPBT | |||||||||||||||||